David Tepper
Appaloosa Management
David Tepper Pfizer Inc stake
total: 317
Appaloosa Management PFE trades
- Total transactions:
- 6
- New positions:
- 2
- Sold out:
- 2
- Added:
- 1
- Reduced:
- 1
- Held since:
- 2016 Q4
- Held for:
- 2 quarters
- Latest activity:
- 2017 Q2
According to 2026 Q2 report, David Tepper doesn't hold any Pfizer Inc (PFE) shares. To date, the estimated cost basis is nearly $32.48 for "buy" trades and estimated average "sell" price is $34.21. Appaloosa Management first purchased PFE in 2015 Q4, initially acquiring about 2.41M shares. David Tepper later completely sold out the position and invested in Pfizer Inc again in 2016 Q4. Since the initial investment in Pfizer Inc (PFE), Appaloosa Management has made 5 more transactions.
When did David Tepper sell Pfizer Inc (PFE)?
David Tepper sold off the entire Pfizer Inc (PFE) position in 2017 Q2.
When did David Tepper buy Pfizer Inc (PFE)?
David Tepper first invested in Pfizer Inc (PFE) in 2015 Q4 at the reported quarter-end price of $32.28 per share.
What's the cost basis of Appaloosa Management's PFE stake?
The estimated cost basis for Pfizer Inc (PFE) stake is around $32.48 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $32.48
- Weighted AVG sell price:
- $34.21
David Tepper's historical trades in Pfizer Inc
6 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2017 Q2
|
0.00%
|
$34.21
|
-100% (-3,021,000)
|
|||
|
2017 Q1
|
1.80%
|
$34.21
|
-37.19% (-1,789,000)
|
|||
|
2016 Q4
|
2.88%
|
$32.48
|
new
|
|||
|
2016 Q2
|
0.00%
|
$29.64
|
-100% (-2,512,250)
|
|||
|
2016 Q1
|
1.49%
|
$29.64
|
+4.15% (+100,000)
|
|||
|
2015 Q4
|
1.77%
|
$32.28
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.